INTRODUCTION: Mastocytosis is an unusual clonal disease of the hematopoietic stem cell. METHODS: This article is based on a selective literature search and on the authors' clinical and pathological experience. RESULTS: The clinical manifestations of mastocytosis range from cutaneous mastocytosis, a common, prognostically favorable presentation, to mast cell leukemia, a rare, life-threatening disease. The mediator-induced symptoms usually respond well to H1 antihistamines. Therapeutic standards for cytoreduction in the progressive, systemic forms of mastocytosis are still lacking. DISCUSSION: Because some of the manifestations of mastocytosis are nonspecific and can be mimicked by other diseases, there is a risk of two types of diagnostic error: Mastocytosis may remain undiagnosed when it is actually present, or it may be diagnosed even though morphological and molecular findings rule out mastocytosis. Well-defined criteria should be used to differentiate mastocytosis from other diseases with a similar clinical presentation.
INTRODUCTION:Mastocytosis is an unusual clonal disease of the hematopoietic stem cell. METHODS: This article is based on a selective literature search and on the authors' clinical and pathological experience. RESULTS: The clinical manifestations of mastocytosis range from cutaneous mastocytosis, a common, prognostically favorable presentation, to mast cell leukemia, a rare, life-threatening disease. The mediator-induced symptoms usually respond well to H1 antihistamines. Therapeutic standards for cytoreduction in the progressive, systemic forms of mastocytosis are still lacking. DISCUSSION: Because some of the manifestations of mastocytosis are nonspecific and can be mimicked by other diseases, there is a risk of two types of diagnostic error: Mastocytosis may remain undiagnosed when it is actually present, or it may be diagnosed even though morphological and molecular findings rule out mastocytosis. Well-defined criteria should be used to differentiate mastocytosis from other diseases with a similar clinical presentation.
Authors: L Escribano; A Orfao; B Díaz-Agustin; J Villarrubia; C Cerveró; A López; M A Marcos; C Bellas; S Fernández-Cañadas; M Cuevas; A Sánchez; J L Velasco; J L Navarro; J F Miguel Journal: Blood Date: 1998-04-15 Impact factor: 22.113
Authors: Jan Cools; Daniel J DeAngelo; Jason Gotlib; Elizabeth H Stover; Robert D Legare; Jorges Cortes; Jeffrey Kutok; Jennifer Clark; Ilene Galinsky; James D Griffin; Nicholas C P Cross; Ayalew Tefferi; James Malone; Rafeul Alam; Stanley L Schrier; Janet Schmid; Michal Rose; Peter Vandenberghe; Gregor Verhoef; Marc Boogaerts; Iwona Wlodarska; Hagop Kantarjian; Peter Marynen; Steven E Coutre; Richard Stone; D Gary Gilliland Journal: N Engl J Med Date: 2003-03-27 Impact factor: 91.245
Authors: Yongsheng Ma; Shan Zeng; Dean D Metcalfe; Cem Akin; Sasa Dimitrijevic; Joseph H Butterfield; Gerald McMahon; B Jack Longley Journal: Blood Date: 2002-03-01 Impact factor: 22.113
Authors: Andres C Garcia-Montero; Maria Jara-Acevedo; Cristina Teodosio; Maria Luz Sanchez; Rosa Nunez; Aranzazu Prados; Isabel Aldanondo; Laura Sanchez; Mercedes Dominguez; Luis M Botana; Francisca Sanchez-Jimenez; Karl Sotlar; Julia Almeida; Luis Escribano; Alberto Orfao Journal: Blood Date: 2006-06-01 Impact factor: 22.113
Authors: Alexander W Hauswirth; Ingrid Simonitsch-Klupp; Martin Uffmann; Elisabeth Koller; Wolfgang R Sperr; Klaus Lechner; Peter Valent Journal: Leuk Res Date: 2004-03 Impact factor: 3.156
Authors: Irina Maric; Jamie Robyn; Dean D Metcalfe; Michael P Fay; Melody Carter; Todd Wilson; Weiming Fu; Jennifer Stoddard; Linda Scott; Marilyn Hartsell; Arnold Kirshenbaum; Cem Akin; Thomas B Nutman; Pierre Noel; Amy D Klion Journal: J Allergy Clin Immunol Date: 2007-07-12 Impact factor: 10.793
Authors: A Mayado; C Teodosio; A C Garcia-Montero; A Matito; A Rodriguez-Caballero; J M Morgado; C Muñiz; M Jara-Acevedo; I Álvarez-Twose; L Sanchez-Muñoz; S Matarraz; C Caldas; J I Muñoz-González; L Escribano; A Orfao Journal: Leukemia Date: 2015-07-08 Impact factor: 11.528
Authors: M Gehlen; A D Lazarescu; C Hinz; N Schmidt; M Pfeifer; M Werner; H F Weidemann; M Schwarz-Eywill; A Maier Journal: Z Rheumatol Date: 2016-09 Impact factor: 1.372
Authors: Kathryn J Lago; Matthew P Shupe; William N Hannah; Gopalrao V N Velagaleti; Christina Mendiola; Veronica Ortega; Brian R Haney Journal: Case Rep Oncol Med Date: 2017-11-26